Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
185.12
+13.84 (+8.08%)
Streaming Delayed Price
Updated: 2:05 PM EDT, Jun 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
↗
March 25, 2023
These companies strive to bring down the cost of developing new therapies.
Via
The Motley Fool
(IQV) - Analyzing IQVIA Hldgs's Short Interest
↗
March 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
↗
March 17, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
↗
March 17, 2023
Via
Benzinga
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
↗
March 06, 2023
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
↗
February 13, 2023
Via
Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
↗
February 10, 2023
Via
Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
March 14, 2023
From
IQVIA
Via
Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
March 01, 2023
From
IQVIA
Via
Business Wire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
↗
February 27, 2023
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...
Via
Benzinga
IQVIA Publishes its 2022 Environmental, Social and Governance Report
February 23, 2023
From
IQVIA
Via
Business Wire
Earnings Outlook For IQVIA Holdings
↗
February 09, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
↗
January 23, 2023
Via
Benzinga
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
↗
February 21, 2023
All three companies have shown consistent revenue and EPS growth.
Via
The Motley Fool
7 Hot Healthcare Stocks With the Potential to Outperform
↗
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
February 10, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
↗
February 10, 2023
With US futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
↗
February 10, 2023
The CNN Money Fear and Greed index showed some decline in the overall sentiment among US investors. US stocks closed lower on Thursday as investors assessed recent batch of corporate earnings.
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
↗
January 13, 2023
Via
Benzinga
Expert Ratings for IQVIA Hldgs
↗
December 06, 2022
Via
Benzinga
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
February 09, 2023
From
IQVIA
Via
Business Wire
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
↗
February 07, 2023
These companies are changing their industries.
Via
The Motley Fool
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
January 31, 2023
From
IQVIA
Via
Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
January 25, 2023
From
IQVIA
Via
Business Wire
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
January 18, 2023
From
IQVIA
Via
Business Wire
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
January 17, 2023
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to...
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
↗
January 11, 2023
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
↗
December 06, 2022
Via
Benzinga
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
↗
December 01, 2022
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
↗
November 17, 2022
Upgrades
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
